TREOSULFAN, THIOTEPA AND FLUDARABINE CONDITIONING REGIMEN PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROMES: A SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Cassanello, Giulio [1 ]
Bagnoli, Filippo [2 ]
Saporiti, Giorgia [2 ]
Goldaniga, Maria [2 ]
Serpenti, Fabio [1 ]
Cavallaro, Francesca [2 ]
Barbullushi, Kordelia [2 ]
Galassi, Giulia [2 ]
Barcellini, Wilma [2 ]
Onida, Francesco [1 ,2 ]
机构：
[1] Univ Milan, Milan, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P164
引用
收藏
页码：264 / 265
页数：2
相关论文
共 50 条
  • [31] Safety and Efficacy of Thiotepa Based Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Single Center Experience
    Elcheikh, Jean
    Massoud, Radwan
    Moukalled, Nour
    Haffar, Basel
    Zaherddine, Ammar
    Maya, Charafeddine
    Mahfouz, Rami
    Bazarbachi, Ali
    BLOOD, 2017, 130
  • [32] Frequency and Impact Of Allogeneic Hematopoetic Stem Cell Transplantation and Preparative Regimen In Patients With High and Intermediate Risk Acute Myeloid Leukemia: A Single Small Center Experience
    Farhan, Shatha
    Carroll, Catherine
    Pelland, Danielle
    Velasco, Jose Carlos
    Peres, Edward
    Janakiraman, Suseela M.
    Wautelet, Susan
    Ruemenapp, Kenneth
    Kuriakose, Philip
    Janakiraman, Nalini
    BLOOD, 2013, 122 (21)
  • [33] Fludarabine and treosulfan conditioning for allogeneic stem cell transplantation; a dose-intense regimen with limited toxicity
    Shimoni, A.
    Rand, A.
    Shem-Tov, N.
    Volchek, Y.
    Yerushalmi, R.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S287 - S287
  • [34] Treosulfan and fludarabine:: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation
    Casper, J
    Knauf, W
    Kiefer, T
    Wolff, D
    Steiner, B
    Hammer, U
    Wegener, R
    Kleine, HD
    Wilhelm, S
    Knopp, A
    Hartung, G
    Dölken, G
    Freund, M
    BLOOD, 2004, 103 (02) : 725 - 731
  • [35] ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA: A SINGLE CENTER EXPERIENCE
    Tiribelli, M.
    Damiani, D.
    Geromin, A.
    Cerno, M.
    Sperotto, A.
    Toffoletti, E.
    Simeone, E.
    Candoni, A.
    Buttignol, S.
    Fanin, R.
    HAEMATOLOGICA, 2012, 97 : 406 - 406
  • [36] Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis
    Krischan Braitsch
    Alix Schwarz
    Katrin Koch
    Mara Hubbuch
    Helge Menzel
    Ulrich Keller
    Katharina S. Götze
    Florian Bassermann
    Peter Herhaus
    Mareike Verbeek
    Annals of Hematology, 2022, 101 : 1311 - 1319
  • [37] Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan
    Oran, Betul
    Giralt, Sergio
    Saliba, Rima
    Hosing, Chitra
    Popat, Uday
    Khouri, Issa
    Couriel, Daniel
    Qazilbash, Muzaffar
    Anderlini, Paolo
    Kebriaei, Partow
    Ghosh, Shubhra
    Carrasco-Yalan, Antonio
    de Meis, Ernesto
    Anagnostopoulos, Athanasios
    Donato, Michele
    Champlin, Richard E.
    de Lima, Marcos
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (04) : 454 - 462
  • [38] Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis
    Braitsch, Krischan
    Schwarz, Alix
    Koch, Katrin
    Hubbuch, Mara
    Menzel, Helge
    Keller, Ulrich
    Goetze, Katharina S.
    Bassermann, Florian
    Herhaus, Peter
    Verbeek, Mareike
    ANNALS OF HEMATOLOGY, 2022, 101 (06) : 1311 - 1319
  • [39] Allogeneic hematopoietic stem cell transplantation after Treosulfan/Fludarabine conditioning in high-risk patients with hematologic malignancies. Dose escalation of Treosulfan.
    Jochen, C
    Blau, W
    Volin, L
    Ruutu, T
    Wandt, H
    Schaefer-Eckart, K
    Holowiecki, J
    Giebel, S
    Aschan, J
    Zander, AR
    Kroeger, N
    Freund, M
    Knauf, WU
    BLOOD, 2003, 102 (11) : 467A - 467A
  • [40] Busulfan and Fludarabine As Conditioning Regimen for Unrelated Allogeneic Stem Cell Transplant: A Single-Center Experience
    Sutamtewagul, Grerk
    Abbi, Kamal Kant Singh
    Farooq, Umar
    Mott, Sarah L.
    Dozeman, Lindsay
    Silverman, Margarida
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S358 - S358
12345